RT @thomashopemd: @DrMHofman @UCSFimaging @SNM_MI @koshkin85 We'll see how it plays out. The #LuMIERE trial is currently in Phase 1 studyi…
Stay Connected
Find below our Twitter-Feed to get the hottest news.
RT @CancerNetwrk: The radiotherapy schedules used in the ATLAS trial reflect recent evidence and guideline changes for its usage in patient…
RT @EllisLab_: @ChrisSweens1 identified ZFP36 (gene)/TTP (protein) as a negative regulator of NFkB. Work not shown-led to the design of a N…
RT @drenriquegrande: My TOP3 abs in #ProstateCancer at #ASCO22: 1. rPFS & cPFS strong surrogate endpoints for OS in mHSPC @ChrisSweens1 2.…
RT @ANZUPtrials: More great coverage on the @ANZUPtrials #TheraP study 3 year results @ASCOPost with @DrMHofman & @CaPsurvivorship #ASCO22…
RT @urotoday: Advanced #ProstateCancer practice informing data presented at @ASCO #GU22. @sartor_oliver @NolaBlueDoo joins @CaPsurvivorship…